Impact Biomedical IBO
NYSE IBO
$5.32 -0.14 (-2.56%)
At close: Oct 2, 2026 · 4:00 PM EDT

Impact Biomedical (IBO) Share-based Compensation (2025 - 2026)

Updated

Impact Biomedical's Share-based Compensation was $1.44 million in Q1 2026, compared with $29,000 a year earlier.

Analysis

Impact Biomedical (IBO) Share-based Compensation (2025 - 2026) Analysis & Trends

For FY2025, Share-based Compensation at Impact Biomedical came in at $190,000, up 900.0% from FY2024.

  • In earlier years, Share-based Compensation was $19,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 458.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 166.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 231.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 249.00 Mn
10 Impact Biomedical 588.70 Mn 591.90 Mn 2,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.44 Mn
Jun 30, 2025 161,000.00
Mar 31, 2025 29,000.00
API Access

Impact Biomedical Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBO&period=max&api_key=YOUR_API_KEY